Description:
Stay informed and gain a competitive edge with this comprehensive and insightful report on the IVD market in the Middle East and Africa from Kalorama Information. Rising national incomes and improved living standards in these regions have led to a higher incidence of heart disease, including high blood pressure, cholesterol, and blood sugar levels, increasing hospital admissions and driving the demand for diagnostic and medical devices.
Report Highlights:
- Countries Covered:
- Middle East: Egypt, Iran, Iraq, Israel, Jordan, Saudi Arabia, Turkey, United Arab Emirates (UAE), and other Mideast countries (Bahrain, Cyprus, Gaza Strip, Kuwait, Lebanon, Oman, Qatar, Syria, West Bank, Yemen).
- Africa: South Africa, Algeria, Congo, Sudan, Libya, Chad, Niger, Angola, Mali, Ethiopia, and more.
Segments Covered:
- Clinical Chemistry
- Immunoassay
- Microbiology
- Point of Care (POC)
- Histology (traditional stains)
- Other Segments: Includes nucleic acid assays, blood bank ABO, sequencing, prenatal tests, and other areas not covered specifically in the above segments.
Market Scope:
- The report provides the IVD market value in U.S. dollars for the years 2021-2026.
- Includes detailed analysis of market growth derived from increased test usage in emerging countries.
- Highlights significant growth in Turkey and Saudi Arabia, driven by investments in healthcare infrastructure and insurance coverage for an increasingly affluent middle class.
Key Insights:
- Anticipated new availability of tests and test systems designed for use in resource-poor settings.
- Increased consolidation of healthcare services worldwide, leading to pricing pressure on all medical devices, including IVDs.
- Expansion opportunities due to increased healthcare insurance availability in emerging countries, enabling more people to access healthcare services.
For further details and to purchase directly, please contact us.
Sample Report: A sample is available as a PDF upon request.
